‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease
PositiveWorld Affairs

Health Canada has made a significant move by approving lecanemab, the first drug aimed at slowing the progression of Alzheimer's disease. This approval is crucial as it brings hope to many patients and families affected by this debilitating condition. With lecanemab already available in countries like the U.S., U.K., Japan, Mexico, and China, its introduction in Canada marks an important step in the global fight against Alzheimer's, potentially improving the quality of life for countless individuals.
— Curated by the World Pulse Now AI Editorial System








